000			01782nam a2200289 i 4500
008			150126s2003 njum b a001 0 eng d
010			_a2003045085
020			_a0470843268 _qcloth : alk. paper
020			_a0470843276 _qpbk. : alk. paper
040			_aDLC _cDLC _dC#P _dOSU _dBAUN _beng _erda
049			_aBAUN_MERKEZ
050	0	0	_aRS380 _b.W34 2003
060	1	0	_aQV778 _bW224 2003
082	0	0	_221
100	1		_aWalsh, Gary _c(Biochemist)
245	1	0	_aBiopharmaceuticals : _bbiochemistry and biotechnology / _cGary Walsh.
250			_a2nd edition
264		1	_aHoboken, NJ : _bJohn Wiley, _cc2003.
300			_axviii, 551 pages : _billustrations ; _c26 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0	0	_t-- Contents _tPreface _tCh. 1 Pharmaceuticals, biologics and biopharmaceuticals _tCh. 2 The drug development process _tCh. 3 The drug manufacturing process _tCh. 4 The cyotkines - the interferon family _tCh. 5 Cytokines: interleukins and tumour necrosis factor _tCh. 6 Haemopoietic growth factors _tCh. 7 Growth factors _tCh. 8 Hormones of therapeutic interest _tCh. 9 Blood products and therapeutic enzymes _tCh. 10 Antibodies, vaccines and adjuvants _tCh. 11 Nucleic acid therapeutics _tApp. 1 Biopharmaceuticals thus far approved in the USA or European Union _tApp. 2 Some Internet addresses relevant to the biopharmaceutical sector _tApp. 3 Two selected monographs reproduced from the European Pharmacopoeia (Products of recombinant DNA technology; Interferon a-2 concentrated solution) _tApp. 4 Manufacture of biological medicinal products for human use _tIndex
650		0	_aPharmaceutical biotechnology.
942			_2lcc _cKT
999			_c33603 _d33603